J&J Gets Ready to Test Ebola Vaccine

The video discusses Johnson & Johnson's efforts to develop an Ebola vaccine, with plans to produce 250,000 doses for clinical trials. The testing has so far been conducted on monkeys, with human trials expected to start in January. The economic implications of vaccine development are highlighted, noting the potential for profit. The video also explores how Ebola news has influenced market trends, with recent positive developments leading to a stock market rally, particularly in healthcare, industrials, and energy sectors.

How did the Ebola situation impact the stock market according to the text?

What was the status of the Ebola patient mentioned in Newark, NJ?